Increased endothelial cell selectivity of triazole-bridged dihalogenated A-ring analogues of combretastatin A–1
Authors:
- 1 March 2012
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 20 (5) , 1749-1759
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting AgentsCancer Treatment Reviews, 2011
- Classification and Toxicities of Vascular Disrupting AgentsClinical Lung Cancer, 2011
- Combretastatin-induced hypertension and the consequences for its combination with other therapiesVascular Pharmacology, 2011
- Microtubule-binding agents: a dynamic field of cancer therapeuticsNature Reviews Drug Discovery, 2010
- Combretastatin A4 Phosphate: A Novel Vascular Disrupting AgentFuture Oncology, 2010
- Anticancer strategies involving the vasculatureNature Reviews Clinical Oncology, 2009
- Promise of New Vascular-Disrupting Agents Balanced With Cardiac Toxicity: Is It Time for Oncologists to Get to Know Their Cardiologists?Journal of Clinical Oncology, 2006
- Combretastatins: from natural products to drug discoveryNatural Product Reports, 2003
- Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4Cellular and Molecular Life Sciences, 1989
- Isolation, Structure, and Synthesis of Combretastatins A-1 and B-1, Potent New Inhibitors of Microtubule Assembly, Derived from Combretum caffrumJournal of Natural Products, 1987